Date: 2012-09-10
Type of information: Company acquisition
Acquired company: Vitalea Science (USA)
Acquiring company: Eckert & Ziegler (Germany) Vitalea Science (USA)
Amount: undisclosed
Terms: Eckert & Ziegler Strahlen- und Medizintechnik AG, through its Californian subsidiary Eckert & Ziegler Isotope Products, Inc, has entered into a definite agreement with Vitalea Science, Inc. for the purchase of all of its stock and assets. This acquisition is part of Eckert & Ziegler strategic move into innovative pharmaceutical services.
Details: Vitalea Science is a pioneering Bioanalytical Contract Research Organization that provides services to researchers and clinicians in drug development supported by validated Accelerator Mass Spectrometry (AMS) technologies. This method is used in pre-clinic and clinic studies for exploring the behavior of drug candidates in the organism. Due to the AMS device’s ultra-sensitivity it is able to detect C14 tagged molecules in microdose levels. Vitalea also provides AMS services for the characterization and identification of non-medical carbon based compounds.
Eckert & Ziegler Isotope Products has been producing instrumentation and calibration standards for over forty five (45) years. Today it is the world's leading manufacturer for nuclear imaging reference and calibration standards and a leading producer of radioactive components for industrial, scientific and medical applications.
Its holding, the German based Eckert & Ziegler AG, is a global isotope technology company that processes radioisotopes as well as develops, manufactures and sells isotope technology components, medical technology equipment and related products. The group employs nearly 600 people worldwide.
Related: bioanalytical CRO
services
